Monday, June 15, 2026

Why South Korea Might Skip Joint Proposal on North Korean Human Rights Resolution: Insights from Minister Chung Dong-young

Unification Minister Chung Dong-young discusses the government's stance on the North Korean human rights resolution, emphasizing non-hostile policies.

Why Strokes Spike When Temperatures Drop—And How You Can Protect Yourself

Sudden temperature drops can increase stroke risk. Quick intervention is crucial for treatment and prevention of cerebrovascular diseases.

Oil Pops 1%+ After U.S. Department of Transportation Warns Ships Away From Iran Near the Strait of Hormuz

U.S. warns vessels to avoid the Strait of Hormuz, causing oil prices to rise over 1% amid escalating Middle East tensions.

Tag: Lazertinib

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Yuhan to Receive $30 Million Milestone From European Launch of Lazertinib Combination Therapy

Yuhan Corporation receives a $30M milestone for Lazertinib's European launch, totaling $300M in payments, aiming for global healthcare leadership.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.